NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

She funded Cognate that was bought by CRL when shorts blew up that symbiotic relationship, and yes, she was able to preserve access to that know how that they had developed through that relationship by taking a part of her payment with this subsidiary of Cognate, Advent. Advent continued to provide the same services to NWBO under the same contract with Cognate, which because of shorts was investigated and apparently was fine as to charges and costs certainly at that point and in fact Cognate had partially funded NWBO with very favorable funding that shorts targeted and blew up as a part of their short strategy.

So the fact that you target this relationship too, is no mystery. It worked for you previously. However, advent is not providing easy funding for NWBO in the same way, so you can’t derive the same shorting benefit by blowing that relationship up.